HINDUSTAN BIO SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.19 INR | +1.11% |
|
-2.27% | -8.18% |
| 2023 | Hindustan Bio Sciences Names CFO | MT |
| 2023 | Hindustan Bio Sciences Limited Appoints Jaison George as CFO | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7.176 | 9.636 | 14.76 | 30.75 | 43.26 | 54.53 |
| Enterprise Value (EV) 1 | 22.7 | 41.46 | 38.76 | 49.17 | 64.83 | 78.99 |
| P/E ratio | -0.32 x | 8.76 x | 18.3 x | -3.26 x | -8.36 x | -133 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.7 x | 0.27 x | 0.76 x | 2.98 x | 10 x | 5.91 x |
| EV / Revenue | 2.2 x | 1.16 x | 1.99 x | 4.77 x | 15.1 x | 8.56 x |
| EV / EBITDA | -0.97 x | 31.1 x | 28.5 x | -5.28 x | -12.9 x | -280 x |
| EV / FCF | -1.45 x | -3.13 x | 5.1 x | 46 x | -55.7 x | -29.1 x |
| FCF Yield | -69.2% | -31.9% | 19.6% | 2.17% | -1.8% | -3.44% |
| Price to Book | 0.35 x | 0.45 x | 0.66 x | 2.36 x | 5.5 x | 7.3 x |
| Nbr of stocks (in thousands) | 10,251 | 10,251 | 10,251 | 10,251 | 10,251 | 10,251 |
| Reference price 2 | 0.7000 | 0.9400 | 1.440 | 3.000 | 4.220 | 5.320 |
| Announcement Date | 9/1/18 | 9/6/19 | 9/7/20 | 6/25/21 | 9/8/22 | 9/1/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 10.31 | 35.64 | 19.43 | 10.32 | 4.306 | 9.223 |
| EBITDA 1 | -23.5 | 1.334 | 1.36 | -9.318 | -5.011 | -0.282 |
| EBIT 1 | -23.6 | 1.227 | 1.246 | -9.399 | -5.045 | -0.3385 |
| Operating Margin | -228.83% | 3.44% | 6.41% | -91.08% | -117.17% | -3.67% |
| Earnings before Tax (EBT) 1 | -22.71 | 1.123 | 1.165 | -9.553 | -5.145 | -0.3795 |
| Net income 1 | -22.75 | 1.1 | 0.8087 | -9.398 | -5.175 | -0.4045 |
| Net margin | -220.65% | 3.09% | 4.16% | -91.08% | -120.19% | -4.39% |
| EPS 2 | -2.220 | 0.1073 | 0.0789 | -0.9200 | -0.5049 | -0.0400 |
| Free Cash Flow 1 | -15.71 | -13.23 | 7.605 | 1.069 | -1.164 | -2.717 |
| FCF margin | -152.33% | -37.11% | 39.13% | 10.36% | -27.03% | -29.45% |
| FCF Conversion (EBITDA) | - | - | 559.07% | - | - | - |
| FCF Conversion (Net income) | - | - | 940.35% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/1/18 | 9/6/19 | 9/7/20 | 6/25/21 | 9/8/22 | 9/1/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 15.5 | 31.8 | 24 | 18.4 | 21.6 | 24.5 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.6608 x | 23.86 x | 17.65 x | -1.977 x | -4.305 x | -86.75 x |
| Free Cash Flow 1 | -15.7 | -13.2 | 7.6 | 1.07 | -1.16 | -2.72 |
| ROE (net income / shareholders' equity) | -71.3% | 5.22% | 3.67% | -53% | -49.5% | -5.28% |
| ROA (Net income/ Total Assets) | -30.8% | 1.64% | 1.39% | -13% | -9.76% | -0.68% |
| Assets 1 | 73.9 | 66.99 | 58.07 | 72.35 | 53.03 | 59.88 |
| Book Value Per Share 2 | 2.000 | 2.110 | 2.190 | 1.270 | 0.7700 | 0.7300 |
| Cash Flow per Share 2 | 0.0200 | 0.1800 | 0.1900 | 0.0200 | 0.0100 | 0.0100 |
| Capex 1 | 0.05 | 0.12 | - | - | 0.03 | - |
| Capex / Sales | 0.47% | 0.34% | - | - | 0.81% | - |
| Announcement Date | 9/1/18 | 9/6/19 | 9/7/20 | 6/25/21 | 9/8/22 | 9/1/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- HINDBIO Stock
- Financials Hindustan Bio Sciences Limited
